(ISSN 2573-4393)
OBM Integrative and Complementary Medicine is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. It covers all evidence-based scientific studies on integrative, alternative and complementary approaches to improving health and wellness.
Topics contain but are not limited to:
The journal publishes a variety of article types: Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.
There is no restriction on paper length, provided that the text is concise and comprehensive. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 5.9 weeks; Submission to Acceptance: 14.7 weeks; Acceptance to Publication: 8 days (1-2 days of FREE language polishing included)
Special Issue
Nutraceuticals and Dietary Supplements to Improve Cardiometabolic Health
Submission Deadline: September 30, 2022 (Open) Submit Now
Guest Editor
Keith R. Martin, PhD, Assistant Professor
Center for Nutraceutical & Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, TN 38152, USA.
Research interests: nutraceuticals; dietary supplements; chronic disease risk.
About the topic:
The purpose of this Special Issue entitled “Nutraceuticals and Dietary Supplements to Improve Cardio-metabolic Health” is to publish a rigorous, impactful volume on how dietary supplementation beneficially influences diverse cardiometabolic risk factors, i.e., metabolic syndrome (MetS), associated with chronic disease. MetS is a cluster of concomitant conditions increasing the risk of heart disease including hypertension, hyperglycemia, abdominal adiposity, and dyslipidemia. Cumulative evidence supports a role for dietary supplements and nutraceuticals in modulating myriad cardiometabolic risk factors including impaired glycemia, insulin resistance, dyslipidemias, and hypertension. The goal of this Special Issue is to provide rigorous evidence from peer-reviewed, empirical studies that supports the association between dietary supplementation of nutritive and/or non-nutritive bioactive factors, viz., nutraceuticals and mitigation of cardiometabolic risk factors. Articles using basic science approaches, animal studies, clinical/translational studies, epidemiological studies, meta-analyses, and behavioral studies are acceptable. Focus areas include the effects of phytochemicals, bioactive compounds, nutraceuticals, macro- and/or micronutrients as supplements singly or as mixtures on vascular biology and/or physiology, endothelial function, inflammation, oxidative stress, dysglycemia, insulin sensitivity, lipid and energy metabolism, blood pressure and cardiac function. Both original and review articles are acceptable with a focus on dietary supplementation and cardiometabolic health from empirical, clinical, and community-based studies.
Keywords:
Cardiometabolic Health; Metabolic Syndrome; Dietary Supplements; Nutraceuticals; Bioactive Agents
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (icm@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
- Newsletter
Vidhi is a Clinical yoga therapist; mentor for yoga therapy training in Krishnamacharya tradition. She holds a MSc in Public health from Kings College London.
Mirela Olympia Fagarasan Palmer
Luigi Fontana, MD, PhD.jpg)
Zhong-Ting (Justin) is a PhD student from Nanyang Technological University (Singapore). He holds BSc in Applied Chemistry and MSc in Environmental Engineering. He was a R&D researcher of NanoMaterials Technology Pte Ltd in Singapore (2006-2012). His current research interests are functional nanomaterials synthesis & design, and their application into environmental/chemical engineering. He has published near 60 SCI papers in Applied Catalysis B, Chemical Engineering Journal and so on with H-Index 23. He also serviced as reviewers over 40 Journals such as Appl. Catal. B, Water Research, Chem. Eng. J, ACS Applied Materials & Interface, etc. He was honored such as “The Bsic Research Achievment 1st Award of CIESC”, “The ZJUT Fund Breeding Distinguished Young Scholars” etc.
Rolf Teschke studied Medicine in Munich and Marburg, where he finished his MD thesis before starting a residency at the Department of Pathology, University of Marburg. Subsequently and with a fellowship of the Deutsche Forschungsgmeinschaft, he worked at the Bronx VA Hospital/Mount Sinai Hospital in New York during 1972–1975 together with Professor Charles S. Lieber and successfully isolated MEOS and expanded its characterization. Back in Germany, he was at the Heinrich-Heine University in Düsseldorf with a focus on alcoholic liver disease, biochemical drug studies, and clinical intoxications by halogenated aliphatic hydrocarbons, where he became a Professor of Medicine. In 1987, he was offered a chief position and appointed as Director of the Medical Department II, City Hospital Hanau, Teaching Hospital of the Johann Wolfgang Goethe University Frankfurt/Main. His clinical and research interests are on liver injury by drugs and herbs including causality assessment by RUCAM in close association with Dr. Gaby Danan in Paris. A perfect cooperation exists also with Professor Tran Dang Xuan of the University of Hiroshima, Japan. Finally, he is the author of more than 275 publications including books and book chapters, and he is editor in chief of scientific journals and member of editorial boards.